dimethoate has been researched along with Pharyngeal Neoplasms in 1 studies
Dimethoate: An organothiophosphorus cholinesterase inhibitor that is used as a systemic and contact insecticide.
dimethoate : A monocarboxylic acid amide that is N-methylacetamide in which one of the hydrogens of the methyl group attached to the carbonyl moiety is replaced by a (dimethoxyphosphorothioyl)sulfanediyl group.
Pharyngeal Neoplasms: Tumors or cancer of the PHARYNX.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huo, D | 1 |
| Jiang, S | 1 |
| Qin, Z | 1 |
| Feng, Y | 1 |
| Yang, R | 1 |
| Lv, L | 1 |
| Li, Y | 1 |
1 other study available for dimethoate and Pharyngeal Neoplasms
| Article | Year |
|---|---|
Omethoate induces pharyngeal cancer cell proliferation and G1/S cell cycle progression by activation of Akt/GSK-3β/cyclin D1 signaling pathway.
Topics: Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Dimethoate; Glycogen Synthase Kinase 3 | 2019 |